アブストラクト | The United States (US) influenza A (H1N1) 2009 monovalent (2009-H1N1) vaccination program began in October 2009. Reports to the vaccine adverse event reporting system (VAERS), a US spontaneous reporting system, were reviewed to identify potential rare events or unusual adverse event (AE) patterns after 2009-H1N1 vaccination. The adverse event profile after 2009-H1N1 vaccine in VAERS ( approximately 10,000 reports) was consistent with that of seasonal influenza vaccines, although the reporting rate was higher after 2009-H1N1 than seasonal influenza vaccines, this may be, at least in part, a reflection of stimulated reporting. Death, Guillain-Barre syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered). |
投稿日 | 2010/09/21 |
投稿者 | Vellozzi, Claudia; Broder, Karen R; Haber, Penina; Guh, Alice; Nguyen, Michael; Cano, Maria; Lewis, Paige; McNeil, Michael M; Bryant, Marthe; Singleton, James; Martin, David; DeStefano, Frank |
ジャーナル名 | Vaccine |
組織名 | Immunization Safety Office, Division of Health Care Quality Promotion, National;Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control;and Prevention, Atlanta, GA 30333, USA. bno1@cdc.gov |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/20850534/ |